Effect of Epstein-Barr Virus infection on gene regulation in immune cells of patients with Immune-Mediated Diseases
- 8 January 2025
- journal article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 150, 103355
Abstract
No abstract availableKeywords
Funding Information
- Chugai Pharmaceutical Co Ltd (JPMJCE1304)
- Japan Science and Technology Agency
- Ministerio de Educación, Cultura y Deporte
- Japan Agency for Medical Research and Development (JP20ek0410074, JP17ek0109103, 19ek0410047)
This publication has 53 references indexed in Scilit:
- Distinct transcriptome architectures underlying lupus establishment and exacerbationCell, 2022
- Genetic and transcriptomic analyses support a switch to lytic phase in Epstein Barr virus infection as an important driver in developing Systemic Lupus ErythematosusJournal of Autoimmunity, 2022
- BRLF1-dependent viral and cellular transcriptomes and transcriptional regulation during EBV primary infection in B lymphoma cellsGenomics, 2021
- Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseasesCell, 2021
- Cell-cycle-dependent EBNA1-DNA crosslinking promotes replication termination at oriP and viral episome maintenanceCell, 2021
- Genetic Control of Chromatin States in Humans Involves Local and Distal Chromosomal InteractionsCell, 2015
- Random-Effects Model Aimed at Discovering Associations in Meta-Analysis of Genome-wide Association StudiesThe American Journal of Human Genetics, 2011
- Glucocorticoids activate Epstein Barr virus lytic replication through the upregulation of immediate early BZLF1 gene expressionBrain, Behavior, and Immunity, 2010
- Antibodies against polypeptides of purified Epstein-Barr virus in sera from patients with connective tissue diseasesJournal of Autoimmunity, 1992
- Possible involvement of epstein‐barr virus in polyclonal b cell activation in sjögren's syndromeArthritis & Rheumatism, 1988